Multiple Myeloma

Loading results

In the News

powered by Ovast
  • FDA: Revlimid Linked To Second Cancers - MedPage Today

    google.com 3 weeks, 1 day ago

    FDA: Revlimid Linked to Second Cancers MedPage Today By Michael Smith, North American Correspondent, MedPage Today Treatment of multiple myeloma with lenalidomide (Revlimid) as maintenance therapy is associated with an increased risk of second primary cancers, the FDA warned. In three trials involving ... FDA warns of malignancy risk with Revlimid FDA: Celgene Drug Revlimid Increases Risk Of Certain New Cancers FDA Issues Extensive Update About Revlimid And Second Cancers -

  • New Drug Shows Promise For Myeloma Patients

    yahoo.com 3 weeks ago

    WEDNESDAY, May 9 (HealthDay News) -- Three new studies confirm that the drug lenalidomide can significantly lengthen the time that people with multiple myeloma experience no worsening of their disease, either after having a stem cell transplant or...

Photos

powered by
Loading photos for 'Multiple Myeloma'

On Twitter

Loading tweets for 'Multiple Myeloma'

Videos

Loading videos for 'Multiple Myeloma'

Additional Info

via Wikipedia
Loading info for 'Multiple Myeloma'
Loading recipes for 'Multiple Myeloma'

Weather -

Loading weather for 'Multiple Myeloma'
Loading More Stories